Screening for Memory Studies

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

NCT03721705 ·Status: COMPLETED ·Phase: PHASE3

Memory and Mental Health in Aging

NCT00043589 ·Status: COMPLETED ·Phase: NA

Memory Aid for Informed Consent in Alzheimer's Research

NCT00105612 ·Status: COMPLETED ·Phase: NA

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers

NCT00785759 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

NCT00322153 ·Status: COMPLETED ·Phase: PHASE3

The Use of Memantine for Prevention of Alzheimer's Disease

NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients

NCT00255086 ·Status: COMPLETED ·Phase: PHASE3

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

NCT01117818 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

NCT00855868 ·Status: COMPLETED ·Phase: PHASE2

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

NCT00334906 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

NCT00702143 ·Status: COMPLETED ·Phase: PHASE2

Memantine for Agitation in Dementia

NCT00371059 ·Status: COMPLETED ·Phase: PHASE4

Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

NCT01465360 ·Status: COMPLETED

A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

NCT00736775 ·Status: COMPLETED ·Phase: PHASE1

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

NCT01028053 ·Status: COMPLETED ·Phase: PHASE3

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

NCT05466422 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

NCT06546995 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

NCT00200538 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

NCT02907567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

NCT03711825 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

NCT02951598 ·Status: ACTIVE_NOT_RECRUITING

Memory and Mental Health in Aging

NCT02988908 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

NCT00257673 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder

NCT02258828 ·Status: COMPLETED ·Phase: PHASE4